1. Gambardella C, Tartaglia E, Nunziata A, Izzo G, Siciliano G, Cavallo F, et al. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients. World J Surg Oncol. 2016; 14(1):247.
Article
2. Conzo G, Tartaglia E, Avenia N, Calo PG, de Bellis A, Esposito K, et al. Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends. World J Surg Oncol. 2016; 14:149.
Article
3. Liang J, Li Z, Fang F, Yu T, Li S. Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. Acta Otorhinolaryngol Ital. 2017; 37(1):1–8.
Article
4. Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solorzano CC. Prophylactic central compartment neck dissection in papillary thyroid cancer and effect on locoregional recurrence. Ann Surg Oncol. 2018; 25(9):2526–2534.
Article
5. Goyal N, Pakdaman M, Kamani D, Caragacianu D, Goldenberg D, Randolph GW. Mapping the distribution of nodal metastases in papillary thyroid carcinoma: Where exactly are the nodes? Laryngoscope. 2017; 127(8):1959–1964.
Article
6. Lodder WL, Lange CA, Teertstra HJ, Pameijer FA, van den Brekel MW, Balm AJ. Value of MR and CT imaging for assessment of internal carotid artery encasement in head and neck squamous cell carcinoma. Int J Surg Oncol. 2013; 2013:968758.
Article
7. Mourad M, Saman M, Stroman D, Lee T, Ducic Y. Carotid artery sacrifice and reconstruction in the setting of advanced head and neck cancer. Otolaryngol Head Neck Surg. 2015; 153(2):225–230.
Article
8. Back LJJ, Aro K, Tapiovaara L, Vikatmaa P, de Bree R, Fernandez-Alvarez V, et al. Sacrifice and extracranial reconstruction of the common or internal carotid artery in advanced head and neck carcinoma: review and meta-analysis. Head Neck. 2018; 40(6):1305–1320.
Article
9. Katsuno S, Takemae T, Ishiyama T, Usami SI. Is carotid reconstruction for advanced cancer in the neck a safe procedure? Otolaryngol Head Neck Surg. 2001; 124(2):222–224.
Article
10. Ozer E, Agrawal A, Ozer HG, Schuller DE. The impact of surgery in the management of the head and neck carcinoma involving the carotid artery. Laryngoscope. 2008; 118(10):1771–1774.
Article
11. Miao B, Lu Y, Pan X, Liu D. Carotid artery resection and reconstruction with expanded polytetrafluoroethylene for head and neck cancer. Laryngoscope. 2008; 118(12):2135–2138.
Article
12. Otsuki N, Nishikawa T, Iwae S, Saito M, Mohri M, Nibu K. Retropharyngeal node metastasis from papillary thyroid carcinoma. Head Neck. 2007; 29(5):508–511.
Article
13. Hartl DM, Leboulleux S, Velayoudom-Cephise FL, Mirghani H, Deandreis D, Schlumberger M. Management of retropharyngeal node metastases from thyroid carcinoma. World J Surg. 2015; 39(5):1274–1281.
Article
14. Reddy A, Verma AK, Mayilvaganan S. Management of retropharyngeal node metastases from thyroid carcinoma. World J Surg. 2016; 40(2):488.
Article
15. Togashi T, Sugitani I, Toda K, Kawabata K, Takahashi S. Surgical management of retropharyngeal nodes metastases from papillary thyroid carcinoma. World J Surg. 2014; 38(11):2831–2837.
Article
16. American Thyroid Association Surgery Working Group. American Association of Endocrine Surgeons. American Academy of Otolaryngology-Head and Neck Surgery. American Head and Neck Society. Carty SE, Cooper DS, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009; 19(11):1153–1158.
Article
17. Machens A, Dralle H. Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann Surg Oncol. 2009; 16(1):171–176.
Article
18. Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg. 2007; 31(5):905–915.
Article
19. Kikumori T, Imai T. Insignificance of prophylactic upper mediastinal lymph node dissection by sternotomy for papillary thyroid carcinoma. Endocr J. 2011; 58(12):1093–1098.
Article
20. Clayman GL, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, et al. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck. 2009; 31(9):1152–1163.
Article
21. Liu J, Wang X, Liu S, Liu X, Tang P, Xu Z. Superior mediastinal dissection for papillary thyroid carcinoma: approaches and outcomes. ORL J Otorhinolaryngol Relat Spec. 2013; 75(4):228–239.
Article
22. Wang LY, Versnick MA, Gill AJ, Lee JC, Sidhu SB, Sywak MS, et al. Level VII is an important component of central neck dissection for papillary thyroid cancer. Ann Surg Oncol. 2013; 20(7):2261–2265.
Article